organization · Reporting owner
Jeremy M. Sclar 2012 Irrevocable Family Trust
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ProMIS Neurosciences Inc.PMN · Entity 6643 | 10% owner | July 25, 2025 | September 30, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ProMIS Neurosciences Inc.
Report date July 25, 2025 · Filed September 30, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, no par valueSEC Table I · non-derivative | Direct | 3,710,459 |
Ending reported balance
After 2025-07-25 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2025-07-25 · Other · Acquired 697,674 · Balance 2,315,111 F1: On July 25, 2025, the Jeremy M. Sclar 2012 Irrevocable Family Trust (the "JS Trust") exercised 697,674 Tranche A purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share. Row 2 · 2025-07-25 · Other · Acquired 697,674 · Balance 3,012,785 F2: On July 25, 2025, the JS Trust exercised 697,674 Tranche B purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share. Row 3 · 2025-07-25 · Other · Acquired 697,674 · Balance 3,710,459 F3: On July 25, 2025, the JS Trust exercised 697,674 Tranche C purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.50 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share. |
| Tranche A Common Share Purchase WarrantsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-07-25 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-07-25 · Other · Disposed 697,674 · Balance 0 F1: On July 25, 2025, the Jeremy M. Sclar 2012 Irrevocable Family Trust (the "JS Trust") exercised 697,674 Tranche A purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share. |
| Tranche B Common Share Purchase WarrantsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-07-25 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2025-07-25 · Other · Disposed 697,674 · Balance 0 F2: On July 25, 2025, the JS Trust exercised 697,674 Tranche B purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share. |
| Tranche C Common Share Purchase WarrantsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-07-25 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2025-07-25 · Other · Disposed 697,674 · Balance 0 F3: On July 25, 2025, the JS Trust exercised 697,674 Tranche C purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.50 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share. |
| Warrant to Purchase Common SharesSEC Table II · derivative / convertible security | Direct | 3,139,533 |
Reported balance
After 2025-07-29 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2025-07-29 · Purchase · Acquired 3,139,533 · Balance 3,139,533 F4: On July 29, 2025, the JS Trust acquired a warrant to purchase 3,139,533 Common Shares at an exercise price of $1.25 per share. The purchase price for the warrant was $0.1875 per Common Share underlying the warrant. The warrant is currently exercisable and expires five years after the date of issuance. |
Filing footnotes · ownership attribution and instrument terms
F1: On July 25, 2025, the Jeremy M. Sclar 2012 Irrevocable Family Trust (the "JS Trust") exercised 697,674 Tranche A purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share.
F2: On July 25, 2025, the JS Trust exercised 697,674 Tranche B purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share.
F3: On July 25, 2025, the JS Trust exercised 697,674 Tranche C purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.50 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share.
F4: On July 29, 2025, the JS Trust acquired a warrant to purchase 3,139,533 Common Shares at an exercise price of $1.25 per share. The purchase price for the warrant was $0.1875 per Common Share underlying the warrant. The warrant is currently exercisable and expires five years after the date of issuance.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 29, 2025 Filed Sep 30, 2025 20:17 UTC | ProMIS Neurosciences Inc. PMN · Entity 6643 | PurchaseWarrant to Purchase Common Shares · Derivative | 3,139,533 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-095035 · tm2523607-3_4seq1.xml · derivative · entry 7 Jeremy M. Sclar 2012 Irrevocable Family Trust · CIK 0002089163 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,139,533 Underlying: Common Shares · 3,139,533 shares Expires not disclosed F4 · derivative.exercise_price: On July 29, 2025, the JS Trust acquired a warrant to purchase 3,139,533 Common Shares at an exercise price of $1.25 per share. The purchase price for the warrant was $0.1875 per Common Share underlying the warrant. The warrant is currently exercisable and expires five years after the date of issuance. F4 · price: On July 29, 2025, the JS Trust acquired a warrant to purchase 3,139,533 Common Shares at an exercise price of $1.25 per share. The purchase price for the warrant was $0.1875 per Common Share underlying the warrant. The warrant is currently exercisable and expires five years after the date of issuance. F4 · derivative.exercise_date: On July 29, 2025, the JS Trust acquired a warrant to purchase 3,139,533 Common Shares at an exercise price of $1.25 per share. The purchase price for the warrant was $0.1875 per Common Share underlying the warrant. The warrant is currently exercisable and expires five years after the date of issuance. F4 · derivative.expiration_date: On July 29, 2025, the JS Trust acquired a warrant to purchase 3,139,533 Common Shares at an exercise price of $1.25 per share. The purchase price for the warrant was $0.1875 per Common Share underlying the warrant. The warrant is currently exercisable and expires five years after the date of issuance. Read SEC document |
| July 25, 2025 Filed Sep 30, 2025 20:17 UTC | ProMIS Neurosciences Inc. PMN · Entity 6643 | OtherTranche C Common Share Purchase Warrants · Derivative | 697,674 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-095035 · tm2523607-3_4seq1.xml · derivative · entry 6 Jeremy M. Sclar 2012 Irrevocable Family Trust · CIK 0002089163 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 697,674 shares Expires not disclosed F3 · derivative.exercise_price: On July 25, 2025, the JS Trust exercised 697,674 Tranche C purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.50 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share. F3 · derivative.exercise_date: On July 25, 2025, the JS Trust exercised 697,674 Tranche C purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.50 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share. F3 · derivative.expiration_date: On July 25, 2025, the JS Trust exercised 697,674 Tranche C purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.50 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share. Read SEC document |
| July 25, 2025 Filed Sep 30, 2025 20:17 UTC | ProMIS Neurosciences Inc. PMN · Entity 6643 | OtherTranche B Common Share Purchase Warrants · Derivative | 697,674 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-095035 · tm2523607-3_4seq1.xml · derivative · entry 5 Jeremy M. Sclar 2012 Irrevocable Family Trust · CIK 0002089163 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 697,674 shares Expires not disclosed F2 · derivative.exercise_price: On July 25, 2025, the JS Trust exercised 697,674 Tranche B purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share. F2 · derivative.exercise_date: On July 25, 2025, the JS Trust exercised 697,674 Tranche B purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share. F2 · derivative.expiration_date: On July 25, 2025, the JS Trust exercised 697,674 Tranche B purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share. Read SEC document |
| July 25, 2025 Filed Sep 30, 2025 20:17 UTC | ProMIS Neurosciences Inc. PMN · Entity 6643 | OtherTranche A Common Share Purchase Warrants · Derivative | 697,674 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-095035 · tm2523607-3_4seq1.xml · derivative · entry 4 Jeremy M. Sclar 2012 Irrevocable Family Trust · CIK 0002089163 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 697,674 shares Expires not disclosed F1 · derivative.exercise_price: On July 25, 2025, the Jeremy M. Sclar 2012 Irrevocable Family Trust (the "JS Trust") exercised 697,674 Tranche A purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share. F1 · derivative.exercise_date: On July 25, 2025, the Jeremy M. Sclar 2012 Irrevocable Family Trust (the "JS Trust") exercised 697,674 Tranche A purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share. F1 · derivative.expiration_date: On July 25, 2025, the Jeremy M. Sclar 2012 Irrevocable Family Trust (the "JS Trust") exercised 697,674 Tranche A purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share. Read SEC document |
| July 25, 2025 Filed Sep 30, 2025 20:17 UTC | ProMIS Neurosciences Inc. PMN · Entity 6643 | OtherCommon Shares, no par value | 697,674 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-095035 · tm2523607-3_4seq1.xml · nonDerivative · entry 3 Jeremy M. Sclar 2012 Irrevocable Family Trust · CIK 0002089163 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,710,459 F3 · kind: On July 25, 2025, the JS Trust exercised 697,674 Tranche C purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.50 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share. F3 · price: On July 25, 2025, the JS Trust exercised 697,674 Tranche C purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.50 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share. Read SEC document |
| July 25, 2025 Filed Sep 30, 2025 20:17 UTC | ProMIS Neurosciences Inc. PMN · Entity 6643 | OtherCommon Shares, no par value | 697,674 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-095035 · tm2523607-3_4seq1.xml · nonDerivative · entry 2 Jeremy M. Sclar 2012 Irrevocable Family Trust · CIK 0002089163 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,012,785 F2 · kind: On July 25, 2025, the JS Trust exercised 697,674 Tranche B purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share. F2 · price: On July 25, 2025, the JS Trust exercised 697,674 Tranche B purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share. Read SEC document |
| July 25, 2025 Filed Sep 30, 2025 20:17 UTC | ProMIS Neurosciences Inc. PMN · Entity 6643 | OtherCommon Shares, no par value | 697,674 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-095035 · tm2523607-3_4seq1.xml · nonDerivative · entry 1 Jeremy M. Sclar 2012 Irrevocable Family Trust · CIK 0002089163 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,315,111 F1 · kind: On July 25, 2025, the Jeremy M. Sclar 2012 Irrevocable Family Trust (the "JS Trust") exercised 697,674 Tranche A purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share. F1 · price: On July 25, 2025, the Jeremy M. Sclar 2012 Irrevocable Family Trust (the "JS Trust") exercised 697,674 Tranche A purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.